AU2003300589A1 - Compositions and methods for detecting and treating neurodegenerative pathologies - Google Patents

Compositions and methods for detecting and treating neurodegenerative pathologies

Info

Publication number
AU2003300589A1
AU2003300589A1 AU2003300589A AU2003300589A AU2003300589A1 AU 2003300589 A1 AU2003300589 A1 AU 2003300589A1 AU 2003300589 A AU2003300589 A AU 2003300589A AU 2003300589 A AU2003300589 A AU 2003300589A AU 2003300589 A1 AU2003300589 A1 AU 2003300589A1
Authority
AU
Australia
Prior art keywords
compositions
detecting
methods
treating neurodegenerative
neurodegenerative pathologies
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003300589A
Other languages
English (en)
Inventor
Laurent Desire
Annelies Resink
Fabien Schweighoffer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ExonHit Therapeutics SA
Original Assignee
ExonHit Therapeutics SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ExonHit Therapeutics SA filed Critical ExonHit Therapeutics SA
Publication of AU2003300589A1 publication Critical patent/AU2003300589A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6827—Hybridisation assays for detection of mutation or polymorphism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Wood Science & Technology (AREA)
  • Neurology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU2003300589A 2002-12-13 2003-12-12 Compositions and methods for detecting and treating neurodegenerative pathologies Abandoned AU2003300589A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0215859A FR2848573B1 (fr) 2002-12-13 2002-12-13 Compositions et methodes pour la detection et le traitement de pathologies neurodegeneratives
FR02/15859 2002-12-13
PCT/FR2003/003700 WO2004055211A2 (fr) 2002-12-13 2003-12-12 Compositions et methodes pour la detection et le traitement de pathologies neurodegénératives

Publications (1)

Publication Number Publication Date
AU2003300589A1 true AU2003300589A1 (en) 2004-07-09

Family

ID=32338791

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003300589A Abandoned AU2003300589A1 (en) 2002-12-13 2003-12-12 Compositions and methods for detecting and treating neurodegenerative pathologies

Country Status (3)

Country Link
AU (1) AU2003300589A1 (fr)
FR (1) FR2848573B1 (fr)
WO (1) WO2004055211A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2929292A1 (fr) * 2008-03-28 2009-10-02 Exonhit Therapeutics S A Sa Procede et methodes de diagnostic de la maladie d'alzheimer

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5994315A (en) * 1995-06-07 1999-11-30 East Carolina University Low adenosine agent, composition, kit and method for treatment of airway disease
FR2775984B1 (fr) * 1998-03-11 2006-09-15 Bioscreen Therapeutics Sa Criblage differentiel qualitatif
WO2001016312A2 (fr) * 1999-08-31 2001-03-08 Ribozyme Pharmaceuticals, Inc. Modulateurs d'expression genetique a base d'acide nucleique
WO2002010449A2 (fr) * 2000-07-28 2002-02-07 Compugen Inc. Bibliotheque d'oligonucleotides destinee a detecter des transcrits d'arn et des variantes d'epissure qui garnissent un transcriptome

Also Published As

Publication number Publication date
WO2004055211A2 (fr) 2004-07-01
FR2848573B1 (fr) 2005-04-08
WO2004055211A3 (fr) 2004-09-30
FR2848573A1 (fr) 2004-06-18

Similar Documents

Publication Publication Date Title
EP1535275B8 (fr) Traitement audio
HK1083443A1 (en) Thiazolidin-4-ones for inhibiting hyak3 proteins
AU2003294358A1 (en) Detecting lipocalin
AU2003219942A1 (en) Composition and process for well cleaning
AU2003271944A1 (en) Methods for making water treatment compositions and compositions thereof
AU2003243599A1 (en) Crimping apparatus
AU2003211296A1 (en) Hairdyeing apparatus
AU2003276528A1 (en) Electrodeionization apparatus
AU2003210777A1 (en) Improved desulfurization process
AU2003274314A1 (en) Detecting apparatus
AU2003217707A1 (en) Means and apparatus for microrefrigeration
AU2003217507A1 (en) Squreness inspection system
AU2003276973A1 (en) Detection methods
AU2003222058A1 (en) Materials and methods for inhibiting wip-1
AU2003209453A1 (en) Transposon
AU2003903868A0 (en) Mill relining apparatus
AU2003264487A1 (en) Substance-atomizing apparatus
AU2003291730A1 (en) Methods and compositions for treating neurodegenerative diseases
AU2003300589A1 (en) Compositions and methods for detecting and treating neurodegenerative pathologies
AU2003211685A1 (en) Switch-charging apparatus
AU2003274309A1 (en) Apparatus
AU2003293672A1 (en) Secretion-collecting apparatus
AU2003278935A1 (en) Method and composition for treating neurodegenerative disorders
AU2003272104A1 (en) Method for detecting mutations
AU2003284818A1 (en) Apparatus

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase